Please use this identifier to cite or link to this item: https://dspace.iiti.ac.in/handle/123456789/19367
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKalia, Himanshuen_US
dc.date.accessioned2026-10-15T11:52:26Z-
dc.date.available2026-10-15T11:52:26Z-
dc.date.issued2026-
dc.identifier.citationKalia, H., Udgire, S., Maurya, V. P., Sharma, I., & Agrawal, A. (2026). Deep learning in Parkinson’s disease. Deep Learning Assessment of Neurological Imaging, 69–80. https://doi.org/10.1016/B978-0-44-330291-6.00012-3en_US
dc.identifier.isbn978-044330291-6-
dc.identifier.otherEID(2-s2.0-105051981019)-
dc.identifier.urihttps://dx.doi.org/10.1016/B978-0-44-330291-6.00012-3-
dc.identifier.urihttps://dspace.iiti.ac.in/handle/123456789/19367-
dc.description.abstractParkinson's disease (PD) is a slowly progressive neurodegenerative disorder, marked by both motor and non-motor symptoms, and it remains tough to diagnose and manage effectively. In recent years, deep learning (DL) has shifted the way researchers and clinicians approach PD, offering tools for automated diagnosis, tracking disease changes, and personalizing treatment plans. This chapter takes a close look at the current DL applications in PD, focusing on early detection methods that rely on neuroimaging, wearable devices, and even voice-based analysis, along with models designed to predict how the disease might progress over time. Architectures like convolutional neural networks (CNNs), recurrent neural networks (RNNs), and emerging transformer models are discussed, particularly in terms of their performance on PD datasets. We also explore how DL is being applied for therapy optimization, including tuning deep brain stimulation (DBS) parameters and predicting drug response patterns. Combining different types of data ranging from imaging to clinical records and genetic profiles is emphasized as a way to create models that are both stronger and easier to interpret. Finally, the chapter addresses major hurdles such as generalization issues, model transparency, and regulatory challenges, while underlining how DL can complement clinical judgment by enabling early interventions, consistent symptom tracking, and a more data-driven approach to precision medicine. Copyright © 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.en_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.sourceDeep Learning Assessment of Neurological Imagingen_US
dc.titleDeep learning in Parkinson’s diseaseen_US
dc.typeBook Chapteren_US
Appears in Collections:IITI DRISHTI CPS Foundation

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetric Badge: